Tower Research Capital (TRC)’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
Sell
-1,672
Closed -$31K 6345
2023
Q3
$31K Sell
1,672
-11,040
-87% -$205K ﹤0.01% 2994
2023
Q2
$141K Buy
12,712
+2,739
+27% +$30.3K ﹤0.01% 1787
2023
Q1
$134K Buy
9,973
+97
+1% +$1.3K ﹤0.01% 1623
2022
Q4
$122K Sell
9,876
-27,496
-74% -$340K 0.01% 1680
2022
Q3
$521K Buy
37,372
+28,953
+344% +$404K 0.01% 1108
2022
Q2
$116K Buy
8,419
+4,457
+112% +$61.4K ﹤0.01% 2178
2022
Q1
$64K Sell
3,962
-3,576
-47% -$57.8K ﹤0.01% 2543
2021
Q4
$123K Sell
7,538
-8,535
-53% -$139K ﹤0.01% 2094
2021
Q3
$239K Buy
16,073
+13,361
+493% +$199K 0.01% 1645
2021
Q2
$54K Buy
2,712
+461
+20% +$9.18K ﹤0.01% 2976
2021
Q1
$52K Sell
2,251
-7,561
-77% -$175K ﹤0.01% 3097
2020
Q4
$242K Buy
9,812
+7,794
+386% +$192K 0.01% 1573
2020
Q3
$84K Sell
2,018
-1,938
-49% -$80.7K ﹤0.01% 3284
2020
Q2
$189K Buy
+3,956
New +$189K 0.01% 1836
2019
Q4
Sell
-550
Closed -$36K 4594
2019
Q3
$36K Buy
+550
New +$36K ﹤0.01% 2032
2019
Q2
Sell
-162
Closed -$18K 4480
2019
Q1
$18K Sell
162
-97
-37% -$10.8K ﹤0.01% 2340
2018
Q4
$26K Buy
259
+160
+162% +$16.1K ﹤0.01% 1750
2018
Q3
$13K Buy
+99
New +$13K ﹤0.01% 2620
2018
Q2
Sell
-1,916
Closed -$118K 4188
2018
Q1
$118K Buy
1,916
+880
+85% +$54.2K 0.01% 1160
2017
Q4
$61K Buy
1,036
+258
+33% +$15.2K 0.01% 1186
2017
Q3
$45K Buy
778
+650
+508% +$37.6K ﹤0.01% 2065
2017
Q2
$15K Buy
128
+86
+205% +$10.1K ﹤0.01% 1383
2017
Q1
$5K Sell
42
-169
-80% -$20.1K ﹤0.01% 2245
2016
Q4
$23K Buy
211
+155
+277% +$16.9K ﹤0.01% 2027
2016
Q3
$9K Sell
56
-85
-60% -$13.7K ﹤0.01% 2166
2016
Q2
$20K Sell
141
-705
-83% -$100K ﹤0.01% 2246
2016
Q1
$109K Buy
+846
New +$109K 0.02% 477
2015
Q3
Sell
-52
Closed -$13K 5040
2015
Q2
$13K Buy
+52
New +$13K ﹤0.01% 2486
2014
Q4
Sell
-7
Closed -$2K 4873
2014
Q3
$2K Buy
+7
New +$2K ﹤0.01% 3902
2014
Q1
Sell
-1,146
Closed -$78K 5100
2013
Q4
$78K Buy
1,146
+785
+217% +$53.4K 0.01% 1006
2013
Q3
$25K Sell
361
-161
-31% -$11.2K ﹤0.01% 2519
2013
Q2
$23K Buy
+522
New +$23K ﹤0.01% 1583